Group Leader in Molecular Infection Medicine

## About the Role The Laboratory for Molecular Infection Medicine Sweden (MIMS) is looking for an excellent young researcher to become Group Leader for innovative research in molecular infection medicine. The topic includes but is not limited to research on the biology of bacteria, viruses, parasites and the microbiome and how these interact with the immune system of the host. MIMS has a strong track record of research into microbial (including viral) pathogenesis, and provides excellent access to national research infrastructure, including cutting edge cryo-electron microscopy and animal biosafety level 3 (ABSL3) facilities. We seek a talented early career researcher who has already produced excellent research work with relevance to molecular infectious medicine, is ready to work independently and shows potential to be a research leader. MIMS intends to recruit a new Group Leader (Researcher) to start in the coming year. Funding is first allocated for a five-year period, with the option of extension up to a total of nine years conditional upon a successful external evaluation in the fourth year. The recruited researcher will receive extensive support to establish their own research group with members at postdoctoral and doctoral level. Successful applicants are also expected to be able to supplement their research budget by attracting national and international research grants. MIMS Group Leaders are expected to conduct a successful research program in synergy with the multidisciplinary research environments in which MIMS is integrated and also participate in collaborations and joint activities that promote research and exchanges within The Nordic EMBL Partnership for Molecular Medicine. Organizationally, the position in question will be affiliated to a suitable department. Affiliation will be decided in consultations with the successful candidate and potential host department, based on where their research best fits. ## Responsibilities * Lead and conduct research in molecular infection medicine within the MIMS research environment. * Seek external funds for funding one's own research. * Conduct education at postgraduate level in the subject area (may be included). * Perform administrative tasks and assignments within the host department (may be included). * Manage personnel and operations as Group Leader. * Establish and lead a research group with postdoctoral and doctoral members. * Collaborate with EMBL and the Nordic EMBL Partnership for Molecular Medicine. ## Requirements * Completed a doctorate or have a foreign degree deemed to be equivalent to a doctorate. * Undergone post-doctoral training and education in relevant research area. * Competence and commitment in training young researchers and supervision of scientific theses. * Obtained a doctoral degree, or corresponding qualifications, no later than two and no more than seven years before the application deadline (to be competitive for ERC Starting Grants and Swedish research council starting grants). * *Note:* If there are special reasons (e.g., absence due to illness, parental leave, clinical practice, appointments of trust for a trade union organisation, or other similar circumstances), an applicant who has completed their degree earlier than that may be considered. * Scientific skills: Evidence of independent research initiatives, innovation, relevance, quality and originality in ongoing and planned research in molecular infection medicine. * Documentation of published original work in which the applicant has had a prominent role. * Received external research grants as main or co-applicant. * Ability to lead and train a team of researchers. * Good cooperative skills. ## Nice to Have * Post-doctoral stay at a university other than the one where the applicant completed his/her PhD. * Referee assignments from international scientific journals. * Experience of teaching in undergraduate and graduate education. * Interest in training the next generation of researchers. * Potential to develop collaborations with EMBL and the Nordic EMBL Partnership for Molecular Medicine. ## Benefits * Extensive support to establish own research group. * Access to national research infrastructure, including cutting edge cryo-electron microscopy and animal biosafety level 3 (ABSL3) facilities. * Integration into multidisciplinary research environments. * Funding allocated for a five-year period, with the option of extension up to a total of nine years conditional upon successful external evaluation.